Maternal asthma, preeclampsia, and risk for childhood asthma at age six

Hooman Mirzakhani; Vincent J. Carey; Thomas F. McElrath; Bruce W. Hollis; George T. O'Connor; Robert S. Zeiger; Leonard Bacharier; Augusto A. Litonjua; Scott T. Weiss

doi:10.1164/rccm.201901-0081LE

Maternal asthma, preeclampsia, and risk for childhood asthma at age six

Hooman Mirzakhani
, Vincent J. Carey
, Thomas F. McElrath
, Bruce W. Hollis
, George T. O'Connor
, Robert S. Zeiger
, Leonard Bacharier
, Augusto A. Litonjua
, Scott T. Weiss

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	638-642
Number of pages	5
Journal	American journal of respiratory and critical care medicine
Volume	200
Issue number	5
DOIs	https://doi.org/10.1164/rccm.201901-0081LE
State	Published - Sep 1 2019

Access to Document

10.1164/rccm.201901-0081LE

Cite this

@article{e916063e8c7a4ac09c70e4e051a7f4bd,

title = "Maternal asthma, preeclampsia, and risk for childhood asthma at age six",

author = "Hooman Mirzakhani and Carey, \{Vincent J.\} and McElrath, \{Thomas F.\} and Hollis, \{Bruce W.\} and O'Connor, \{George T.\} and Zeiger, \{Robert S.\} and Leonard Bacharier and Litonjua, \{Augusto A.\} and Weiss, \{Scott T.\}",

note = "Funding Information: VDAART (Vitamin D Antenatal Asthma Reduction Trial) was supported by U01HL091528 and R01HL091528 from the NHLBI. H.M. was supported by T32-HL00742707, L30-HL129467-01, and 2L30 HL129467-02A1 from the NHLBI. Funding Information: Supported by AstraZeneca and by Menarini Group through its affiliate, Berlin Chemie.",

year = "2019",

month = sep,

day = "1",

doi = "10.1164/rccm.201901-0081LE",

language = "English",

volume = "200",

pages = "638--642",

journal = "American journal of respiratory and critical care medicine",

issn = "1073-449X",

number = "5",

}

TY - JOUR

T1 - Maternal asthma, preeclampsia, and risk for childhood asthma at age six

AU - Mirzakhani, Hooman

AU - Carey, Vincent J.

AU - McElrath, Thomas F.

AU - Hollis, Bruce W.

AU - O'Connor, George T.

AU - Zeiger, Robert S.

AU - Bacharier, Leonard

AU - Litonjua, Augusto A.

AU - Weiss, Scott T.

N1 - Funding Information: VDAART (Vitamin D Antenatal Asthma Reduction Trial) was supported by U01HL091528 and R01HL091528 from the NHLBI. H.M. was supported by T32-HL00742707, L30-HL129467-01, and 2L30 HL129467-02A1 from the NHLBI. Funding Information: Supported by AstraZeneca and by Menarini Group through its affiliate, Berlin Chemie.

PY - 2019/9/1

Y1 - 2019/9/1

UR - https://www.scopus.com/pages/publications/85071783511

U2 - 10.1164/rccm.201901-0081LE

DO - 10.1164/rccm.201901-0081LE

M3 - Letter

C2 - 31059286

AN - SCOPUS:85071783511

SN - 1073-449X

VL - 200

SP - 638

EP - 642

JO - American journal of respiratory and critical care medicine

JF - American journal of respiratory and critical care medicine

IS - 5

ER -

Maternal asthma, preeclampsia, and risk for childhood asthma at age six

Access to Document

Other files and links

Cite this